Evidence map›Paper›PMID 40697328›Full record

ArticleMethodsX2025

Development of an explainable machine learning model for Alzheimer's disease prediction using clinical and behavioural features.

Rajkumar Govindarajan, K Thirunadanasikamani, Komal Kumar Napa, S Sathya, J Senthil Murugan, K G Chandi Priya

Erratum issuedAbstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Rajkumar GovindarajanDepartment of Computer Science and Engineering, St. Peter's Institute of Higher Education and Research, Avadi, Chennai, India.
K ThirunadanasikamaniDepartment of Computer Science and Engineering, St. Peter's Institute of Higher Education and Research, Avadi, Chennai, India.
Komal Kumar NapaDepartment of Artificial Intelligence and Data Science, Saveetha Engineering College, Chennai, India.
S SathyaDepartment of Electronics and Communication Engineering, S. A. Engineering College, Chennai, India.
J Senthil MuruganDepartment of Computer Science and Engineering, Vel Tech High Tech Dr. Rangarajan Dr. Sakunthala Engineering College, Chennai, India.
K G Chandi PriyaDepartment of Science and Humanities (General Engineering Division), R.M.K. College of Engineering and Technology, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article presents a reproducible machine learning methodology for the early prediction of Alzheimer's disease (AD) using clinical and behavioural data. A comparative analysis of multiple classification algorithms was conducted, with the Gradient Boosting classifier yielding the best performance (accuracy: 93.9 %, F1-score: 91.8 %). To improve interpretability, SHapley Additive exPlanations (SHAP) were integrated into the workflow to quantify feature contributions at both global and individual levels. Key predictive variables such as Mini-Mental State Examination (MMSE), Activities of Daily Living (ADL), cholesterol levels, and functional assessment scores were identified and visualized using SHAP-based insights. A user-friendly, interactive web application was developed using Streamlit, allowing real-time patient data input and transparent model output visualization. This method offers a practical tool for clinicians and researchers to support early diagnosis and personalized risk assessment of AD, thus aiding in timely and informed clinical decision-making. Accurate Prediction: Gradient Boosting model achieved 93.9 % accuracy for early Alzheimer's detection. Explainability: SHAP values provided interpretable insights into key clinical features. Clinical Tool: A Streamlit-based web app enabled real-time, explainable predictions for users.

Indexed as

Alzheimer's disease predictionExplainable artificial intelligenceGradient boosting classifierSHAP valuesStreamlit web application

Identifiers

PMID40697328
PMCPMC12281133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.